CLOV vs DXCM · rev $1.37B vs P/E 63, rev $4.03B
Clover Health Investments Corp (CLOV) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
CLOV currently screens at market cap $1.55B. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the CLOV and DXCM stock pages for the full models.
Not investment advice.